Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
2.
Health Qual Life Outcomes ; 17(1): 6, 2019 Jan 11.
Artigo em Inglês | MEDLINE | ID: mdl-30634997

RESUMO

BACKGROUND: Clostridium difficile infection (CDI) is associated with a substantial Quality of life impact on patients that has not been so far measured with a generic validated instrument. METHODS: A prospective study was performed in 7 French acute-care settings in patients presenting with a bacteriologically-confirmed CDI. The EQ-5D-3 L was filled in by patients at 7 ± 2 days after CDI diagnosis to describe their state of health at that date as well as their state of health immediately before the CDI episode (baseline). Individual utility decrement was obtained by subtracting the corresponding utilities. The Quality Adjusted Life Year (QALY) loss was calculated by multiplying the days spent from baseline to the date of the interview, by the decrement of utility. A multivariate analysis of variance of the utility decrement according to CDI and patients characteristics was performed. RESULTS: Eighty patients were enrolled (mean age: 69.4 years, 55% females). The utility scores dropped from a mean 0.542 (SD: 0.391) at baseline to 0.050 (SD: 0.404) during the CDI episode with a mean adjusted utility decrement of 0.492 (SD: 0.398) point. This decrement increased significantly with CDI severity (Zar score ≥ 3) (p = 0.001), in patients with a positive baseline utility (p = 0.032), in women as compared to men (p = 0.041) and in patients aged more than 65 years (p = 0.041). No association with the Charlson index was found. The associated QALY loss not integrating the excess mortality was 0.028 (SD: 0.053). CONCLUSIONS: The impact on quality of life of CDI episodes is major and translates in a substantial QALY loss despite their short duration.


Assuntos
Infecções por Clostridium , Qualidade de Vida , Anos de Vida Ajustados por Qualidade de Vida , Idoso , Feminino , França , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Índice de Gravidade de Doença , Inquéritos e Questionários
3.
Cardiovasc Toxicol ; 18(6): 579-582, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-29948594

RESUMO

Lacosamide, one of the last antiepileptic drugs marketed, can cause extension of PR interval. Precautions are recommended when used in elderly and with other drugs extending PR interval. Cases of severe third-degree atrioventricular block have been reported only in post-marketing case reports when used at high-doses and remain rare. We report the case of an 88-year-old woman treated with bisoprolol, who experienced a complete atrioventricular block after initiation of lacosamide for epilepsy associated with neurodegenerative disease. This dramatic event required a pacemaker implementation. Not being dose-dependent (initiation dosage used), it seemed partially explained by drug-drug interaction with bisoprolol.


Assuntos
Anticonvulsivantes/efeitos adversos , Bloqueio Atrioventricular/induzido quimicamente , Nó Atrioventricular/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Lacosamida/efeitos adversos , Antagonistas de Receptores Adrenérgicos beta 1/efeitos adversos , Idoso de 80 Anos ou mais , Bloqueio Atrioventricular/diagnóstico , Bloqueio Atrioventricular/fisiopatologia , Bloqueio Atrioventricular/terapia , Nó Atrioventricular/fisiopatologia , Bisoprolol/efeitos adversos , Estimulação Cardíaca Artificial , Interações Medicamentosas , Eletrocardiografia , Feminino , Humanos , Fatores de Risco , Resultado do Tratamento
4.
Soins Gerontol ; (83): 11-4, 2010.
Artigo em Francês | MEDLINE | ID: mdl-20560272

RESUMO

The high frequency of fractures in the elderly after minimum trauma is explained by osteoporosis, due to the weakening of the bone in old age. Osteodensitometry enables a diagnosis to be made before the occurrence of the first fracture. Regular physical exercise, increased calcium intake and medication enable the incidence of fractures to be limited, even if the use of drugs is limited by compliance and polymedication in extreme old age.


Assuntos
Fraturas Ósseas/epidemiologia , Osteoporose/epidemiologia , Idoso de 80 Anos ou mais , Calcinose/tratamento farmacológico , Calcinose/etiologia , Colecalciferol/uso terapêutico , Tratamento Farmacológico/normas , Feminino , Fraturas Ósseas/etiologia , Humanos , Masculino , Osteoporose/complicações , Osteoporose/fisiopatologia , Osteoporose/reabilitação , Fatores de Risco
5.
Ann Med Interne (Paris) ; 154(2): 78-84, 2003 Mar.
Artigo em Francês | MEDLINE | ID: mdl-12746643

RESUMO

We report 7 cases of respiratory syncytial virus (RSV) infections among elderly patients hospitalized for acute lower tract infection during the winter months. The median age was 95 years (range: 79-106 years). 6 patients were living in nursing homes. All patients had chronic cardiopulmonary conditions. Clinical symptoms included upper respiratory tract symptoms for 3 of them and lower respiratory tract symptoms for all of them. Three patients developed a severe infection with acute respiratory failure. The chest X ray showed an interstitial infiltrate in 3 cases, a consolidation in one case. All patients received oxygen, respiratory physical therapy, nebulized B-agonists and antibiotics. Corticosteroids were used for 4 patients. Progress was favorable for all patients and none died. Diagnosis was obtained in a few hours by direct antigen detection by enzyme immunoassays (EIA) in sputum. Respiratory syncytial virus infection is a common cause of respiratory tract infection in the elderly, during the winter months. Clinical manifestations are similar to influenza infections. Detection of RSV antigens from sputum specimens may be a useful and rapid diagnostic method and merits further evaluation in the elderly. Early diagnosis of respiratory syncytial virus infection should be encouraged to allow the implementation of effective infection control procedures and avoid inadequate therapies.


Assuntos
Infecções por Vírus Respiratório Sincicial/complicações , Infecções Respiratórias/etiologia , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Infecções por Vírus Respiratório Sincicial/diagnóstico , Infecções por Vírus Respiratório Sincicial/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...